Delivery Order SPE2DB22D1202-SPE2DB23FHLY1
Award Date
4/21/23
Potential Completion Date
5/12/23
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,978.09 fixed-price delivery order is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a completion date of November 25, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of pharmaceutical products, including the medication TESTOPEL 75 MG PELLETS 100S, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $7,956.18 and a completion date of June 27, 2024. It is a firm fixed-price delivery order contract without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
This federal contract award, valued at $3,978.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564594203 - TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product. The contract does not have a set-aside designation and is a Delivery Order with a Firm Fixed Price pricing type. It has an ultimate completion date of May 31, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,115.58, is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program and appears to be...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP20Y, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,978.09, is for the delivery of 4564821333 TESTOPEL 75 MG PELLETS 100S and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,978.09 contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a medical product, with a period of performance through August 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $7,956.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a prescription medication. The delivery order has a completion date of October 1, 2024 and is a Firm Fixed Price contract. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, has been awarded numerous...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $7,956.18 firm fixed price delivery order is for the supply of 100 units of the medication TESTOPEL 75 MG PELLETS. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a firm fixed price of $11,934.27 and runs through September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued up to $3,978.09, is for the delivery of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, to a location in Conshohocken, Pennsylvania. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through...